Novel germline MLH1 and MSH2 mutations in Latvian lynch syndrome families

Experimental Oncology

Volumn 34, Issue 1, 2012, Pages 49-52

  Berzina D ^a,b   Irmejs, A ^a,b   Kalniete, D ^a,b   Borosenko V ^a,b   Nakazawa Miklasevica M ^a,b   Ribenieks, K ^a,b   Trofimovics G ^a,b   Gardovskis, J ^a,b   Miklasevics E ^a,b  

^a RIGA STRADINS UNIVERSITY   (Latvia)

^b PAULS STRADINS CLINICAL UNIVERSITY HOSPITAL   (Latvia)

Author keywords

Germline mutations; Lynch syndrome; Mismatch repair genes; MLH1; MSH2

Indexed keywords

PROTEIN MLH1; PROTEIN MSH2;

ADULT; AGED; ARTICLE; CANCER RISK; CLINICAL ARTICLE; COLORECTAL CANCER; FAMILY STUDY; GENE MUTATION; GENE REARRANGEMENT; GENE SEQUENCE; GENETIC HETEROGENEITY; GENETIC RISK; GENETIC SCREENING; GERM LINE; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HIGH RISK POPULATION; HUMAN; LATVIA; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FAMILY; FEMALE; GERM-LINE MUTATION; HUMANS; LATVIA; MALE; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; NUCLEAR PROTEINS; PEDIGREE;

EID: 84862488973     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Lynch HT, Lynch JF, Attard TA. Diagnosis and management of hereditary colorectal cancer syndromes: Lynch syndrome as a model. CMAJ 2009; 181: 273-80.
2. Stigliano V, Assisi D, Cosimelli M, et al. Survival of hereditary non-polyposis colorectal cancer patients compared with sporadic colorectal cancer patients. J Exp Clin Cancer Res 2008; 27: 39.
3. Liu B, Parsons R, Papadopoulos N, et al. Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nature Med 1996; 2: 169-74. (Pubitemid 26057553)
4. Mangold E, Pagenstecher C, Friedl W, et al. Spectrum and frequencies of mutations in MSH2 and MLH1 identified in 1.721 german families suspected of hereditary nonpolyposis colorectal cancer. Int J Cancer 2005; 116: 692-702. (Pubitemid 41099700)
5. Vasen HFA, Moslein G, Alonso A, et al. Guidelines for the clinical managment of Lynch syndrome (hereditary non-polyposis cancer). J Med Genet 2007; 44: 353-62. (Pubitemid 46953715)
6. Meyer LA, Broaddus RR, Lu KH. Endometrial cancer and Lynch syndrome: clinical and pathologic considerations. Cancer Control 2009; 16: 14-22.
7. Irmejs A, Borosenko V, Melbarde-Gorkusa I, et al. Nationwide study of clinical and molecular features of hereditary non-polyposis colorectal cancer (HNPCC) in Latvia. Anti-cancer Res 2007; 27: 653-8. (Pubitemid 46374990)
8. Kurzawski G, Suchy J, Kładny J, et al. Germline MSH2 and MLH1 mutational spectrum in HNPCC families from Poland and the Baltic States. J Med Genet 2002; 39: e65.
9. Irmejs A, Gardovskis A, Borosenko V, et al. Hereditary colorectal cancer (CRC) program in Latvia. Hereditary Cancer Clin Pract 2003; 1: 49-53.
10. Kolodner RD, Hall NR, Lipford J, et al. Structure of the human MLH1 locus and analysis of a large hereditary nonpolyposis colorectal carcinoma kindred for MLH1 mutations. Cancer research 1995; 55: 242-8.
11. Kolodner RD, Hall NR, Lipford J, et al. Structure of the human MSH2 locus and analysis of two Muir-Torre kindreds for MSH2 mutations. Genomics 1994; 24: 516-26.
12. Borošenko V, Irmejs A, Melbārde-Gorkuša I, et al. Initial results of colorectal polyposis research in Latvia. Anti-cancer Res 2009; 29: 711-6.
13. Vanags A, Štrumfa I, Gardovskis A, et al. The characteristics of hereditary colorectal cancer syndromes bay population screening. Acta Chirurgica Latv 2010; 10/2: 3-8.
14. Lynch HT, de la Chapelle A. Genetic susceptibility to non-polyposis colorectal cancer. J Med Genet 1999; 36: 801-18. (Pubitemid 29520569)
15. Hampel H, Frankel WL, Martin E, et al. Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol 2008; 26: 5783-8.
16. Wallace E, Hinds A, Campbell H, et al. A cross-sectional survey to estimate the prevalence of family history of colorectal, breast and ovarian cancer in a Scottish general practice population. British Journal of Cancer 2004; 91; 1575-1579. (Pubitemid 39489853)
17. Vanags A, Štrumfa I, Gardovskis A, et al. Population screening for hereditary and familial cancer syndromes in Valka district of Latvia. Hereditary Cancer Clin Pract 2010; 8: 8.
18. Cunningham JM, Kim C-Y, Christensen ER, et al. The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas. Am J Hum Genet 2001; 69: 780-90. (Pubitemid 32868523)
19. Hitchins MP, Wong JJL, Suthers G, et al. Inheritance of a cancer-associated MLH1 germ-line epimutation. N Engl J Med 2007; 356: 697-705.
20. Devlin LA, Graham CA, Price JH, et al. Germline MSH6 mutations are more prevalent in endometrial cancer patient cohorts than Hereditary Non Polyposis Colorectal Cancer cohorts. Ulster Med J 2008; 77: 25-30. (Pubitemid 351148703)
21. Picelli S, Vandrovcova J, Jones S, et al. Genome-wide linkage scan for colorectal cancer susceptibility genes supports linkage to chromosome 3q. BMC Cancer 2008; 8: 87.
22. Nyström-Lahti M, Wu Y, Moisio A-L, et al. DNA mismatch repair gene mutations in 55 kindreds with verified or putative hereditary non-polyposis colorectal cancer. Hum Mol Genet 1996; 5: 763-9. (Pubitemid 26171291)
23. Scott RJ, McPhillips M, Meldrum CJ, et al. Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds. Am J Hum Genet 2001; 68: 118-27. (Pubitemid 32048366)
24. Caldes T, Godino J, de la Hoya M, et al. Prevalence of germline mutations of MLH1 and MSH2 in hereditary nonpolyposis colorectal cancer families from Spain. Int J Cancer 2002; 98: 774-9. (Pubitemid 34225631)